ArticleCureus2026
Beyond Analgesia: Preliminary Observations of Appetite and Weight Changes After Spinal Cord Stimulation.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinal cord stimulation (SCS) is an established therapy for chronic pain, primarily used for analgesia; however, its broader physiologic effects remain poorly characterized. This retrospective observational cohort study evaluated whether SCS implantation was associated with changes in appetite and body weight in patients with chronic pain. Eighteen patients with permanent SCS implants (10 females, eight males; aged 43-75 years) were reviewed. Outcomes included weight loss, weight gain, or no change in weight, along with self-reported appetite changes following implantation. Weight loss was observed in six patients (33%), ranging from 6.8 to 22.6 kgs, all of whom reported decreased appetite. Two patients (11%) experienced weight gain, while 10 patients (56%) demonstrated no significant weight change. Overall, seven patients (39%) reported decreased appetite after SCS implantation; however, decreased appetite did not consistently translate into measurable weight loss. These findings suggest that SCS may influence appetite regulation in a subset of patients with chronic pain, potentially through central neuromodulatory mechanisms beyond analgesia. Larger prospective studies with standardized metabolic and weight assessments are needed to further evaluate this relationship and its clinical implications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.